DAFTAR PUSTAKA

1. Dahlan Z. Pneumonia bakteri. Dalam : Dahlan Z, Amin Z. SurotoYA,

editor. Tata Laksana Respirologi Respirasi Kritis. Edisi ke-2. Jakarta :
PERPARI, 2013.p 53-87.

2. Skrupty PL, Micek TS. Optimizing therapy for MRSA pneumonia. Semin
resp crit care med. 2007;615-623.

3. Rubinstein E, Kollef HM, Nathwan D. Pneumonia caused by methicillin –

resistant staphylococcus aureus. Clin Infect Disease. 2008;46:1-5.

4. Kollef HM, Short A, Tabak PY, Gupta V, Larry, Liu ZL, et al.
Epidemiology and outcomes of health-care associated pneumonia. Chest.
2005;128(6):3854-62.

5. Magil SS, Edward JR, Bamberg, Beldavs ZG, Dumiyati G, Kainer MA, et
al. Multistate point prevalence survey of health care-associated infections.
N Engl J Med. 2014;37(13):1198-2008.

6. Marlowe ME, Bankowski JM. Conventional and molecular methods for the
detection of methicillin–resistant staphylococcus aureus. J Clin Microbiol.
2011;53-56.

7. Goel N. CA-MRSA: An emerging pathogen. JIMSA. 2010; 23(1): 9-12.

8. Huang SS, Hinrichsen LV, Datta R, Spurchise L, Miroshnik I, Nelson K, et

al. Methicillin–resistant staphylococcus infection and hospitalization in high
– risk patients in the year following detection. PloS ONE. 2011;6(9) :1–6.

9. Jung JW, Kang AY, Park SM, Park CS, Leem YA, Kim YE et al. Prediction
of methicillin-resistant staphylococcus aureus in patients with non-
nosocomial pneumonia. BMC Infect Dis. 2013;13:3-7

10. Leem YA, Jung JW, Kang A Y, Park CS, Kim JY, Hwang DE, et al.
Comparison of methicillin-resistant staphylococcus aureus community-
acquired and healthcare associated pneumonia. Yonsei Med J. 2014;55(4):
967-70.

11. Kwon JS, Jeon T, Seo D, Moonjoon NA, Choi E, Son WJ et al. Quantitative
PCR for etiologic diagnosis of methicillin–resistant staphylococcus aureus
pneumonia in intensive care unit. J Tuberc Respir Dis. 2012;72:293-301.

59
12. Nakou, Woodhead, Torres. MRSA as a cause of community–acquired
pneumonia. Eur Resp J. 2009;34:1013-14.

13. Karuniawati A, Rosa Y, Budianti A, Prasetyo SD. Hasil Uji Kepekaan

Bakteri Terhadap Berbagai Antibiotik Tahun 2012. Laboratorium
Mikrobiologi Klinik Departemen Mikrobiologi Fakultas Kedokteran
Universitas Indonesia. Jakarta. 2012;4-22.

14. Rasyid. Gambaran Kuman Methicilin- Resistant Staphylococcus Aureus

(MRSA) di Laboratorium Mikrobiologi RS Dr. M. Djamil Padang. 2014

15. Zurita J. Diagnosis and susceptibility testing of methicilin–resistant

staphylococcus aureus in Latin America. Braz J Infect Dis. 2010;14(2):S97-
S106.

16. Atay T, Gulay Z. Comparison of PBP2a latex agglutination test with disk
diffusion, mecA PCR and VITEX for the detection of methicillin resistant
staphylococcus aureus isolates. ANKEM Derg. 2004;18(4):205-208.

17. Hudzicki J. Kirby bauer disk diffusion susceptibility test protocol. J Am Soc
Microbiol. 2009; 1-22. Diakses http: // microbel libraly.org.

18. Abbadi S, Youssef, Nomenqani D, Abdel Moneim SA. Rapid identification

of methicillin resistant staphylococcus aureus using real time PCR. Advanc
Infect Dis. 2013;3:44-49.

19. Aydemir O. The role of multiplex PCR test in identification of bacterial

pathogens in lower respiratory tract infections. J Med Sci. 2014;(3):1-5.

20. Alipour F. Evaluation of different methods to detect methicillin resistance in

staphilococcus aureus (MRSA). J Infect Public Health. 2014;(7):186-191.

21. Batabyal B, Kundu GKR, Biswas S. Methicillin-resistant staphylococcus

aureus: a brief review. Int Res J Biologic Sci. 2012;1(7):65-71.

22. Odonkor TS, Addo KK. Evaluation of three methods for detection of
methicillin resistant staphylococcus aureus (MRSA). Int J Biol Med Res.
2011;2(4):1031-34.

23. Mohanasoundaram KM, Lalitha MK. Comparison of phenotypic versus

genotypic methods in the detection of methicillin resistance in
staphylococcus aureus. Indian J Med Res. 2008;127:78-84.

60
24. Datta P, Gulati N, Singla N, Vasdeva RH, Bala K, Chander J, et al.
Evaluation of various methods for the detection of methicillin–resistant
staphylococcus aureus strains and susceptibility. Indian J Med Microbiol.
2011;60:1613-16.

25. Serin CD, Pullukcu H, Cicek C, Sipahi RO, Tasbakan S, Atalay S, et al.
Bacterial and viral etiology in hospitalized community acquired pneumonia
with molecular methods and clinical evaluation. J Infect Dev Ctries.
2014;8(6):510-18.

26. American Thoracic Society. Guidelines for management of adults with

hospital–acquired,ventilator–associated, and healthcare-associated
pneumonia pneumonia. Am J Resp Crit Care Med. 2005;171:388-416.

27. Dahlan Z. Pneumonia. Dalam: Setiati S, Alwi I, Sudoyo AW, Simadibrata

M, Setyohadi B, Syam AF, editor. Buku Ajar Ilmu Penyakit Dalam. Edisi
ke-6. Jakarta : Pusat Penerbitan Ilmu Penyakit Dalam FKUI; 2014.p.1608-
19

28. Dhar R. Pneumonia : review of guidelines. Journal of Association Physician

India. 2012;60:25-28

29. Murphy LM, Jiaquan, Kenneth D. Kochanek. National Vital Statistics

Reports. Deaths : Final Data for 2010. 2013;61(4):1-6

30. Hartono B Kusumobroto BS, Purwanto H, Hasnawati, Brahim R. Profil

Kesehatan Indonesia 2007. Jakarta : Departemen Kesehatan RI; 2008,p.46-8

31. Perhimpunan Dokter Paru Indonesia. Pneumonia Nosokomial. Pedoman

Diagnosis & Penatalaksanaan di Indonesia. PDPI. 2003;1-15.

32. Mizgerd PJ. Acute lower respiratory tract infection. N Engl J Med. 2008;
358:16-27.

33. Defres S, Marwick, Nathwani. MRSA as a cause of lung infection including

airway infection, community acquired pneumonia and hospital-acquired
pneumonia. Eur Respir J. 2009;34:1190-96.

34. Sing DY. Pathophysiology of community acquired pneumonia. Journal of

Association Physician India. 2012;6:7-9.

35. British Thoracic Society. Guidelines for the management of community

acquired pneumonia in adults 2004 update. 2004:1-22.

61
36. File Thomas. Impact of community-acquired methicillin resistant
staphylococcus aureus in the hospital setting. Cleve Clin J of Med. 2007;
74(4):6-11.

37. Eigner U. Veldenzer A. Holfelder M. Validation of the fluoro type @

MRSA assay for the rapid identification of methicillin–resistant
staphylococcus aureus directly from patient material. J Microbiol. 2014;1-4.

38. Wirahjasa IG, Panji PA. Pengelolaan infeksi akibat methicillin - resistant
staphylococcus aureus. Majalah Kedokteran Terapi Intensif. 2012;2(3):134-
143.

39. Rybak JM, Plant. Community acquired methicillin-resistant staphylococcus

aureus pharmacotherapy : A Review. Pharmacotherapy. 2005;25(1):74-85

40. Short FA. Myer EA, Huang BD, Nathanson HB, Emons FM, Kollef HM et
al. A risk score for identifying methicillin–resistant staphylococcus aureus
in patients presenting to the hospital with pneumonia. BMC Infect Dis.
2013;268-78.

41. Gordon JR, Lowy DF. Pathogenesis of methicillin-resistant staphylococcus

aureus infection. Clin Infect Dis. 2008;46:S350-59.

42. Zetola N, Francis J, Nuermberger E, Bishai W, Community acquired

methicilin resistant staphylococcus aureus : an emerging threat. Lancet
Infect Dis. 2005;5:275-86.

43. Lindberg M. Carisson M. MRSA-colonized persons’ and healtcare

personels’ experiences of patients experience of patients-professional
interactions in and responsibilitas for infection prevention in sweden. J
Infect and Public Health. 2014;7:427-435.

44. Yamamoto T, Hung CW, Takano T, Nishiyama A Genetic nature and

virulence of community associated methicillin-resistant staphylococcus. Bio
Medicine. 2013;2(8):1-4.

45. Foster. The staphylococcus aureus “ superbug”. J Clin Invest. 2004;114(12):

1693-95.

46. Tacconelli E, Angelis DG. Pneumonia due to methicillin–resistant

staphylococcus aureus: clinical feature, diagnosis and management. Curr
Opin Pulm Med. 2009;15:218-22

62
47. Lobo JL, Reed DK, Wunderick GR. Expanded clinical presentation of
community–acquired methicillin-resistant staphylococcus aureus pneumonia
Am Colleg of Chest Phy. 2009;130-5.

48. Tsai FY, Ku HY. Necrotizing pneumonia: a rare complication of pneumonia

requiring special consideration. Curr Opin Pulm Med. 2012;18(3):246-52.

49. Bolivar MA, Gonzalez G. Latex immunoagglutination assays. J Macromol

Sci. 2005; 45 : 59-98.

50. Akcam ZF, Tinaz BG, Kaya O, Tigli A, Ture E, Hosuglu S et al. Evaluation
of methicillin resistance by cefoxitin disk diffusion and PBP2a latex
agglutination test in mecA-positive staphylococcus aureus, and comparison
of mecA with femA, fem B, fem X positives. J Microbiol Res. 2009;164:
400-3.

51. Brown JD, Walpole. Evaluation of the mastalatex latex agglutination test for
methicillin resistance in Staphylococcus aureus grown on different
screening media. J Antimicrobiol Chemother. 2001;47:148-189.

52. Oxoid. Penicillin –Binding Protein (PBP2´) Latex Agglutinationan Test DR

0900A diakses dari : http://
www.oxoid.com/UK/blue/prod_detail/prod_detail.asp?pr=DR0900

53. Ian Hart. A test for the early detection of MRSA : clinical benefits and
financial savings. CLI. 2004.

54. Handoyo D, Rudiretna A. Prinsip umum dan pelaksanaan polymerase chain

reaction (PCR). Unitas. 2001;9(1):17-29.

55. Zang K, Sparling J, Chow LB, Elsayed S, Hussain Z, Church LD, et al. New
quadriplex PCR assay for detection of methicillin and mupirosin resistance
and simultaneous discrimination of staphylococcus aureus from coagulase –
negative staphylococci. J Clin Microbiol. 2004; 42(11):4947-54.

56. Pillai MM, Latha R, Sarkar G. Detection of methicillin resistance in

staphylococcus aureus by polimerase chain reaction and conventional
methods : a comparative study. J lab Physic. 2014;(4)2:83-8.

57. Precautions to prevent the spread of MRSA in healthcare-settings. 2008.

Diakses : http://www.cdc.gov/mrsa/healtcare/clinicians/precautions.html.

63
58. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al.
Clinical practice guidelines by the infectious disease society of America for
the treatment of methicillin resistant staphylococcus aureus infection in
adults and children. Clin Infect Dis. 2011;52:1-38.

59. Shorr FA, Haque N, Taneja C, Zervus M, Lamerato L, Kothari S, et al.

Clinical and economic outcomes for patients with health care-associated
staphylococcus aureus pneumonia. J Clin Microbiol. 2010;48(9):3258-62.

60. Taneja C, Haque N, Osler G, Shor FA, Zilber S, Kyan OP, Reyes CK et al.
Clinical and economic outcomes in patiens with community-acquired
staphylococcus aureus. J Hospital med. 2010;9(5):528-34.

61. Setiati S, Rizka A. Imunosenesens. Dalam: Setiati S, Alwi I, Sudoyo AW,

Simadibrata M, Setyohadi B, Syam AF, editor. Buku Ajar Ilmu Penyakit
Dalam. Edisi ke-6. Jakarta : Pusat Penerbitan Ilmu Penyakit Dalam FKUI;
2014.p.3680-85.

62. Wooten DA, Winston LG. Risk factors for methicillin–resistant

staphylococcus aureus in patients with community-onset and hospital–onset
pneumonia. J Resp Med. 2013;107:1266-70.

63. Haddadin SA, Fappiano AS, Lipsett PA. Methicillin resistant

staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J.
2002;78:385-392.

64. Tong CY, Davis SJ, Eichenberg E, Holland LT, Fowler GV. Staphylococcus
aureus infection : epidemiology, pathophysiology, clinical manifestations,
and management. Clin Microbiol Rev. 2015;28(3):603-607.

65. Tadros M, Williams V, Coleman LB, McGeer JA, Haider S, Lee C, et al.
Epidemiologi and outcome of pneumonia caused by methicillin–resistant in
Canadian hospital. PLoS ONE. 2013;1-7.

66. Zainah H, Hasan S, Nakhieh R, Arshad S, Zervos M. Epidemiology and

outcome of methicillin–resistant staphylococcus aureus health–care
associated pneumonia. Case Report. Clinical Medicine. 2013;38-43.75

67. Minejema E, Lou M, Nielberg, Beringer WA. Patients presenting to the

hospital with MRSA pneumonia: differentiating characteristic and outcomes
with empiric treatment. BMC Infect Dis. 2014;14:2-7.

64
68. Gross EA, Schooneveld CT, Olsen MK, Rupp EM, Bui HT, Forsung E.
Epidemiologi and predictor of multidrug-resistant community –acquired and
health-care associated pneumonia. Antimicrob Agents Chemother. 2014;
58(9): 5262-68.

69. Laboratory detection of : oxacillin / methicillin – resistant staphylococcus

aureus Centers for Disease Control and Prevention diakses dari
www.cdc.gov/HAI/settings/lab/_MRSA html.

70. Chawla R. Epidemiology, etiology, and diagnosis of hospital-acquired

pneumonia and ventilator-associated pneumonia in Asian countries. Am J
Infect Control. 2008;36:S93-100.

71. Chalmers DJ, Taylor KJ, Singanayagam A, Fleming BG, Akram RA,
Mandal P et al. Epidemiology, antibiotic therapy, and clinical outcomes in
health care-associated pneumonia: A UK cohort study. Clin Infect Dis.
2011; 53(2):107-113.

72. Van Griethuysen A, Pouw M, van Leeuwen N, Heck M, Willemse P,

Buiting A et al. Rapid slide latex agglutination test for detection of
methicillin resistance in staphylococcus aureus. J Clin Microbiol
1999;37:(9);2789-92

73. Van Leeuwen WB, van Pelt C, Luijendijk AD, Verbrugh HA, Goessens
FW. Rapid detection of methicillin resistance in staphylococcus aureus
isolates by the MRSA-screen latex agglutination test. J Clin Microbiol.
1999;37(9): 3029--3030

74. Louie L, Matsumura OS, Louie MC, Simor. Evaluation of three rapid
metods for detection of methicillin resistance in staphylococcous aureus. J
Clin Microbiol. 2000;2170-7.

75. Sadaka MS, Ghazzawy EF, Harfoush RA, Meheissen. Evaluatiaon of

different methods for rapid diagnosis of methicillin–resistance in
staphylococcus aureus. African J Microbiol Res. 2009:3(2):49-55.

76. Sangeetha, John J, Ranjith. Comparison of different phenotypic methods

with PCR detection of mecA gene for detection of methicillin –resistant
staphylococcus aureus (MRSA). Int J Pharm Sci. 2012; 4 (suppl 4):495-7.

77. Panduan Bersama PDPI, PERDICI, PAPDI, PERDOSSI, IKABDI, PERKI.

Panduan tata laksana hospital-acquired pneumonia, ventilator–associated
pneumonia dan healthcare-associated pneumonia pasien dewasa. 2008.

65
78. Niederman SM. Treatment option for nosocomial pneumonia due to
MRSA. J infect. 2009; 59(S1)S25-S31.

79. Linosefa. Karakteristik isolat staphylococcus peragi manitol yang resisten

metisilin sebagai flora normal pada pasien ICU rumah sakit tersier. Tesis.
Program Studi Pendidikan Dokter Spesialis Mikrobiologi Klinik FKUI
2015.

80. Adhayuni M. Kejadian kolonisasi methicillin – resistant staphylococcus

aureus (MRSA) pada nasal perawat ICU RS. M. Djamil Padang berdasarkan
lama masa tugas. Skripsi. FKUA 2014.

81. Bertrand X, Lozano J.M, Slekovec C, Thouverez, Hocquet D, Talon D et al.

Temporal effects of infection control practices and the use of antibiotics on
the incidence of MRSA. J Hospital Infect. 2012:(82) :164-69.

82. Gould MI, Controlling hospital MRSA. J Global Antimikrobial Resistance

2013;43-5.

83. Rossolini MG, Arena F, Pecile P, Pollini S. Update on the antibiotic

resistance crisis. J Curr opin Pharm. 2014;18: 56-60

84. Short FA, Zilberberg, Reichley R, Kan J, Hoban A, Hoffmans et al.

Validation of clinical score for assessing the risk of resistant pathogens with
pneumonia presenting to the emergency departement. Clin Infect Dis.
2012;54(2):193-8.

66